Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bloomage BioTechnology's Total Liabilities for the quarter that ended in Mar. 2026 was ¥1,590 Mil.
Bloomage BioTechnology's quarterly Total Liabilities
increased
from Sep. 2025 (¥1,379.30 Mil) to Dec. 2025 (¥1,577.36 Mil) and
increased
from Dec. 2025 (¥1,577.36 Mil) to Mar. 2026 (¥1,590.38 Mil).
Bloomage BioTechnology's annual Total Liabilities
increased
from Dec. 2023 (¥1,486.58 Mil) to Dec. 2024 (¥1,816.93 Mil) but then
declined
from Dec. 2024 (¥1,816.93 Mil) to Dec. 2025 (¥1,577.36 Mil).
Bloomage BioTechnology Total Liabilities Related Terms
Bloomage BioTechnology Total Liabilities Historical Data
* Premium members only.
The historical data trend for Bloomage BioTechnology's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Bloomage BioTechnology's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bloomage BioTechnology (SHSE:688363) has a Total Liabilities of ¥1,590 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bloomage BioTechnology and its competitors.
Is Bloomage BioTechnology's Total Liabilities too high?
Bloomage BioTechnology's current Total Liabilities is ¥1,590 Mil. Overall, Bloomage BioTechnology has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bloomage BioTechnology's Total Liabilities compare to LIN and SHW?
Bloomage BioTechnology's Total Liabilities of ¥1,590 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bloomage BioTechnology and its competitors. Bloomage BioTechnology's current Total Liabilities is ¥1,590 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bloomage BioTechnology stock overvalued right now?
Based on GuruFocus' analysis, Bloomage BioTechnology (SHSE:688363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.76, compared to a current price of ¥37.19 — trading 13% below its estimated fair value. The current Total Liabilities is ¥1,590 Mil. Bloomage BioTechnology's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bloomage BioTechnology (SHSE:688363), the current Total Liabilities is ¥1,590 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bloomage BioTechnology (SHSE:688363) Overvalued in 2026?
Based on GuruFocus' analysis, Bloomage BioTechnology stock appears to be undervalued.
The current stock price of ¥37.19 is trading 13% below its estimated GF Value™ of ¥42.76.
GuruFocus considers Bloomage BioTechnology to be Modestly Undervalued.
Key valuation signals for SHSE:688363:
Total Liabilities: ¥1,590 Mil
GF Value™: ¥42.76 vs. price of ¥37.19 (13% below fair value)
No single metric tells the full story. See the SHSE:688363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.
94GF Score
Get the complete analysis for SHSE:688363
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688363 has been successfully added to your 
